(4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone CAS:189028-93-1

(4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone exhibits significant potential in pharmaceutical applications, particularly in the following areas: Antibacterial Activity: Known for its efficacy against Gram-positive bacteria, including resistant strains such as methicillin-resistant Staphylococcus aureus (MRSA), making it valuable in combating bacterial infections. Structure-Activity Relationship (SAR) Studies: Its complex structure aids in understanding SAR for developing new antibiotics with enhanced potency and reduced resistance development. Clinical Trials: Under investigation for its safety and efficacy in clinical trials targeting bacterial infections, contributing to the development of novel antibacterial agents. Mechanism of Action Studies: Research focuses on elucidating its precise mechanism of action to optimize treatment strategies and broaden its spectrum of activity. (4S)-3-[5-(4-Fluorophenyl)-1,5-dioxopenyl]-4-phenyl-2-oxazolidinone represents a promising candidate in the ongoing battle against antibiotic resistance, emphasizing its role in future therapeutic innovations and pharmaceutical developments.